<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2018-24-3-309-320</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-637</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Cодержание адипокинов в сыворотке крови и экспрессия рецепторов к адипонектину 1‑го типа в мышечной ткани артерий у пациентов с артериальной гипертензией молодого и среднего возраста</article-title><trans-title-group xml:lang="en"><trans-title>Serum adiponectin and expression of adiponectin receptor 1 in the arterial muscular tissue in young and middle-aged hypertensive patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саковская</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakovskaia</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент Института терапии и инструментальной диагностики,</p><p>пр. Острякова, д. 2, Владивосток, 690002</p></bio><bio xml:lang="en"><p>MD, Assistant, Institute of Therapy and Instrumental Diagnostics,</p><p>2 Ostraykova street, Vladivostok, 690002</p></bio><email xlink:type="simple">fpctheray@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Невзорова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nevzorova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, директор Института терапии и инструментальной диагностики,</p><p>пр. Острякова, д. 2, Владивосток, 690002</p></bio><bio xml:lang="en"><p>MD, PhD, DSc, Professor, Head, Institute of Therapy and Instrumental Diagnostics, </p><p>2 Ostraykova street, Vladivostok, 690002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коцюрбий</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotsyurbiy</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент, заведующий кафедрой патологической анатомии и судебной медицины,</p><p>пр. Острякова, д. 2, Владивосток, 690002</p></bio><bio xml:lang="en"><p>MD, PhD, Associate Professor, Head, Department of Pathological Anatomy and Forensic Medicine,</p><p>2 Ostraykova street, Vladivostok, 690002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костив</surname><given-names>Р. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostiv</surname><given-names>R. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент хирургического института,</p><p>пр. Острякова, д. 2, Владивосток, 690002</p></bio><bio xml:lang="en"><p>MD, PhD, Associate Professor, Institute of Surgery,</p><p>2 Ostraykova street, Vladivostok, 690002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бродская</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Brodskaya</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор Института терапии и инструментальной диагностики,</p><p>пр. Острякова, д. 2, Владивосток, 690002</p></bio><bio xml:lang="en"><p>MD, PhD, DSc, Professor, Institute of Therapy and Instrumental Diagnostics,</p><p>2 Ostraykova street, Vladivostok, 690002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Репина</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Repina</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент Института терапии и инструментальной диагностики,</p><p>пр. Острякова, д. 2, Владивосток, 690002</p></bio><bio xml:lang="en"><p>MD, Assistant, Institute of Therapy and Instrumental Diagnostics,</p><p>2 Ostraykova street, Vladivostok, 690002</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное&#13;
образовательное учреждение высшего образования «Тихоокеанский государственный медицинский университет» Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Pacific State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>30</day><month>07</month><year>2018</year></pub-date><volume>24</volume><issue>3</issue><fpage>309</fpage><lpage>320</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Саковская А.В., Невзорова В.А., Коцюрбий Е.А., Костив Р.Е., Бродская Т.А., Репина Н.И., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Саковская А.В., Невзорова В.А., Коцюрбий Е.А., Костив Р.Е., Бродская Т.А., Репина Н.И.</copyright-holder><copyright-holder xml:lang="en">Sakovskaia A.V., Nevzorova V.A., Kotsyurbiy E.A., Kostiv R.E., Brodskaya T.A., Repina N.I.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/637">https://htn.almazovcentre.ru/jour/article/view/637</self-uri><abstract><p>Цель исследования — оценить содержание сывороточных адипокинов и степень экспрессии рецепторов адипонектина 1‑го типа (AdipoR1) в артериях мелкого и среднего диаметра мышечной ткани плеча у пациентов с неосложненной артериальной гипертензией (АГ) молодого и среднего возраста.</p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование были включены всего 50 пациентов с АГ 1–3‑й степени от 18 до 60 лет, 30 из которых были прооперированы по поводу травматических переломов плеча. Контрольную группу составили 20 практически здоровых некурящих добровольцев, 10 из которых были прооперированы по поводу травматических переломов плеча. Уровень адипонектина и лептина в крови определяли методом иммуноферментного анализа. Биоптат мышечной ткани обрабатывали иммуногистохимическим методом с использованием первичных поликлональных кроличьих антител против AdipoR1 (Santa Сruze, sc‑99183, США, 1:500). Для оценки результатов использована программа Statistica 6.0. Вычислен критерий U Манна–Уитни. Применен метод корреляционного анализа Спирмена. Различия принимались как статистически значимые при р &lt; 0,05.</p></sec><sec><title>Результаты</title><p>Результаты. Пациенты с АГ молодого и среднего возраста имеют более высокие показатели индекса массы тела (ИМТ), окружности талии (ОТ), содержания общего холестерина, липопротеинов низкой плотности по сравнению с лицами контрольной группы без АГ. Содержание адипонектина у пациентов с АГ составило 5,48 (4,11; 6,95) мкг/мл (р &gt; 0,05). Среднее значение концентрации лептина у пациентов с АГ составило 3,0 (2,2; 3,5) мкг/мл (р &gt; 0,05). В группе женщин с АГ содержание лептина составило 3,4 (2,7; 3,6) мкг/мл (р &lt; 0,05). У женщин установлена положительная связь содержания лептина с ИМТ (r = 0,6; p = 0,001), ОТ (r = 0,5; p = 0,02). В контрольной группе структура сосудистой стенки не нарушена. В группе пациентов с АГ установлено два типа ремоделирования сосудов мышечной ткани. В мелких сосудах преобладают процессы эластофиброза, в сосудах среднего диаметра — циркулярная гипертрофия, где выражена экспрессия AdipoR1, достигающая 14,1% (12,22; 16,83). Экспрессия AdipoR1 в мышечной стенке сосудов контрольной группы минимальна и составляет 1,09% (0,37; 1,41). Установлена взаимосвязь между увеличением AdipoR1 и уровнем глюкозы (r = 0,5; p = 0,02) у женщин с АГ, а также AdipoR1 и липопротеинами высокой плотности (ЛПВП) (r = –0,6; p = 0,04) и у мужчин, и у женщин с АГ.</p></sec><sec><title>Выводы</title><p>Выводы. У женщин с АГ установлено повышение содержания лептина в сыворотке крови, которое прямо коррелирует с показателями ОТ и ИМТ. У пациентов с АГ установлено два типа ремоделирования в виде развития артериолосклероза сосудов мелкого диаметра и гипертрофического циркулярного ремоделирования сосудов среднего диаметра, где наблюдается увеличение содержания количества меток к AdipoR1, достигающее 14%. Не установлено статистически значимой взаимосвязи между сывороточным уровнем адипонектина и количеством AdipoR1 во всех группах пациентов. Установлена положительная связь между содержанием глюкозы и количеством AdipoR1 в артериях среднего диаметра у женщин с АГ и отрицательная связь между количеством AdipoR1 и уровнем ЛПВП в сыворотке крови. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To evaluate the serum adipokines and the degree of expression of adiponectin type 1 receptors (AdipoR1) in the brachial arteries with small and medium diameter of the muscular tissue in young and middleaged patients with hypertension (HTN).</p></sec><sec><title>Design and methods</title><p>Design and methods. We included 50 patients with HTN 1–3 degree (18 to 60 years old), 30 underwent surgery due to trauma-related fractures on the shoulder. The control group included 20 otherwise healthy non-smoking volunteers, 10 underwent surgery due to trauma-related fractures of the shoulder. The serum levels of adiponectin and leptin were determined by the method of enzyme immunoassay. The biopsy of the muscle tissue were analyzed by the immunohistochemistry using primary polyclonal rabbit antibodies against AdipoR1 (Santa Cruze, sc‑99183, USA, 1:500). The data were processed using software Statistica 6.0. The Mann–Whitney criterion U, and Spearman’s correlation analysis were applied. Differences were considered statistically significant at p &lt; 0,05.</p></sec><sec><title>Results</title><p>Results. Young and middle-aged patients with HTN had higher body massindex (BMI), waist circumference (WC), cholesterol, low-density lipoprotein cholesterol than control group. The serum adiponectin level was 5.48 (4,11; 6,95) μg/ml in HTN patients (p &gt; 0,05), the leptin — 3,0 (2,2; 3,5) μg/ml (p &gt; 0,05). Women with HTN showed higher leptin level — 3,4 (2,7; 3,6) μg/ml (р &lt; 0,05). Women had a positive relationship between leptin and BMI (r = 0,6; p = 0,001), WC (r = 0,5; p = 0,02). The control group demonstrated normal vascular wall structure. Patients with HTN had two types of muscle vessel remodeling. The elastofibrosis was found in small vessels, circular hypertrophy was found in medium diameter vessels. Expression of AdipoR1 was the highest in the area of hypertrophy, reaching 14,1% (12,22; 16,83). Expression of AdipoR1 in the muscular wall of the vessels of the control group was the lowest and constituted 1,09% (0,37; 1,41). The increase in AdipoR1 correlated with the glucose level (r = 0,5; p = 0,02) in women with HTN and AdipoR1/high density lipoprotein (HDL) (r = –0,6; p = 0,04) in men and women with HTN.</p></sec><sec><title>Conclusions</title><p>Conclusions. Women with HTN had increased serum leptin. Leptin directly correlated with BMI and WC. HTN patients demonstrate two types of vascular remodeling: arteriolosclerosis in small vessels and hypertrophic circular remodeling in vessels of medium diameter. There were 14% AdipoR1 labels in hypertrophic area. No significant relationship between serum adiponectin and AdipoR1 were found in the patient groups. Glucose level positively correlated with AdipoR1 in the arteries of medium diameter in hypertensive women, while serum HDL level negatively correlated with AdipoR1 in all patient groups. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>адипонектин</kwd><kwd>лептин</kwd><kwd>артериальная гипертензия</kwd><kwd>рецепторы адипонектина 1‑го типа (AdipoR1)</kwd><kwd>ремоделирование сосудов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>adiponectin</kwd><kwd>leptin</kwd><kwd>hypertension</kwd><kwd>adiponectin type 1 receptors (AdipoR1)</kwd><kwd>vascular remodeling</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А., Баланова Ю.А., Шальнова С.А., Деев А.Д., Артамонова Г.В., Гатагонова Т.М. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13 (4):4–14. doi:10.15829/1728-8800-2014-4-4-14 [Boytsov SA, Balanova YA, Shalnova SA, Deev AD, Artamonova GV, Gatagonova TM et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control (the ESSE-RF study). Cardiovascular Therapy and Prevention. 2014;13(4):4–14. doi:10.15829/1728-8800-2014-4-4-14 In Russian.].</mixed-citation><mixed-citation xml:lang="en">Бойцов С.А., Баланова Ю.А., Шальнова С.А., Деев А.Д., Артамонова Г.В., Гатагонова Т.М. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;13 (4):4–14. doi:10.15829/1728-8800-2014-4-4-14 [Boytsov SA, Balanova YA, Shalnova SA, Deev AD, Artamonova GV, Gatagonova TM et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control (the ESSE-RF study). Cardiovascular Therapy and Prevention. 2014;13(4):4–14. doi:10.15829/1728-8800-2014-4-4-14 In Russian.].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Концевая А.В., Шальнова С.А., Баланова Ю.А., Деев А.Д., Артамонова Г.В., Гатагонова Т.М., и др. Социально-экономические градиенты поведенческих факторов риска в российской популяции (по результатам исследования ЭССЕ-РФ). Кардиоваскулярная терапия и профилактика. 2015;14(4):59– 67. doi:10.15829/1728-8800-2015-4-59-67 [Kontsevaya AV, Shalnova SA, Balanova YA, Deev AD, Artamonova GV, GatagonovaTM et al. Social and economic gradients of behavioral risk factors in Russian population (the ESSE-RF study). Cardiovascular Therapy and Prevention. 2015;14(4):59–67. doi:10.15829/1728-8800-2015-4-59-67 In Russian].</mixed-citation><mixed-citation xml:lang="en">Концевая А.В., Шальнова С.А., Баланова Ю.А., Деев А.Д., Артамонова Г.В., Гатагонова Т.М., и др. Социально-экономические градиенты поведенческих факторов риска в российской популяции (по результатам исследования ЭССЕ-РФ). Кардиоваскулярная терапия и профилактика. 2015;14(4):59– 67. doi:10.15829/1728-8800-2015-4-59-67 [Kontsevaya AV, Shalnova SA, Balanova YA, Deev AD, Artamonova GV, GatagonovaTM et al. Social and economic gradients of behavioral risk factors in Russian population (the ESSE-RF study). Cardiovascular Therapy and Prevention. 2015;14(4):59–67. doi:10.15829/1728-8800- 2015-4-59-67 In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Парфенова Н.С., Танянский Д. А. Адипонектин: благоприятное воздействие на метаболические и сердечнососудистые нарушения. Артериальная гипертензия. 2013;19(1): 84–96. doi:10.18705/1607-419X2013-19-1-84-96 [Parfenova NS, Tanyanskiy DA. Adiponectin: beneficial effects on metabolic and cardiovascular dysfunctions. Arterial’naya Gipertenziya = Arterial Hypertension. 2013;19 (1):84–96. doi:10.18705/1607-419X2013-19-1-84-96 In Russian].</mixed-citation><mixed-citation xml:lang="en">Парфенова Н.С., Танянский Д. А. Адипонектин: благоприятное воздействие на метаболические и сердечнососудистые нарушения. Артериальная гипертензия. 2013;19(1): 84–96. doi:10.18705/1607-419X 2013-19-1-84-96 [Parfenova NS, Tanyanskiy DA. Adiponectin: beneficial effects on metabolic and cardiovascular dysfunctions. Arterial’naya Gipertenziya = Arterial Hypertension. 2013;19 (1):84–96. doi:10.18705/1607-419X 2013- 19-1-84-96 In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ghomari-Boukhatem H, Bouchouicha A, Mekki K, Chenni K, Belhadj M, Bouchenak M. Blood pressure, dyslipidemia and inflammatory factors are related to body mass index in scholar adolescents. AMS. 2017;13(1):46–52. doi:10.5114/aoms.2017.64713</mixed-citation><mixed-citation xml:lang="en">Ghomari-Boukhatem H, Bouchouicha A, Mekki K, Chenni K, Belhadj M, Bouchenak M. Blood pressure, dyslipidemia and inflammatory factors are related to body mass index in scholar adolescents. AMS. 2017;13(1):46–52. doi:10.5114/aoms. 2017.64713</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Peri-Okonny PA, Ayers C, Maalouf N, Sandeep RD, James AL, Jarett DB et al. Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study. Diab Metab Res Rev. 2017;33: e2840. doi:org/10.1002/dmrr.2840</mixed-citation><mixed-citation xml:lang="en">Peri-Okonny PA, Ayers C, Maalouf N, Sandeep RD, James AL, Jarett DB et al. Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study. Diab Metab Res Rev. 2017;33: e2840. doi:org/10.1002/dmrr.2840</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sawicka M, Janowska J, Chudek J. Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system. Int J Cardiol. 2016; 1;222:581–589. doi:10.1016/j.ijcard.2016.07.054.</mixed-citation><mixed-citation xml:lang="en">Sawicka M, Janowska J, Chudek J. Potential beneficial effect of some adipokines positively correlated with the adipose tissue content on the cardiovascular system. Int J Cardiol. 2016; 1;222:581–589. doi:10.1016/j.ijcard.2016.07.054.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol. 2017;28(4):347–354. doi:10.1097/MOL.0000000000000431.</mixed-citation><mixed-citation xml:lang="en">Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol. 2017;28(4):347–354. doi:10.1097/ MOL.0000000000000431.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Takeuchi S, Wada K, Uozumi Y, Otani N, Osada H, Nagatani K et al. Adiponectin receptor 1 expression is associated with carotid plaque stability. Neurology India. 2013;61(3):249–53. doi:10.4103/0028–3886.115063.</mixed-citation><mixed-citation xml:lang="en">Takeuchi S, Wada K, Uozumi Y, Otani N, Osada H, Nagatani K et al. Adiponectin receptor 1 expression is associated with carotid plaque stability. Neurology India. 2013;61(3):249–53. doi:10.4103/ 0028–3886.115063.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ikonomidis I, Kadoglou N, Tsiotra PC, Kollias A, Palios I, Fountoulaki K et al. Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens. 2012;25(7): 746–55. doi:10.1038/ajh.2012.42</mixed-citation><mixed-citation xml:lang="en">Ikonomidis I, Kadoglou N, Tsiotra PC, Kollias A, Palios I, Fountoulaki K et al. Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens. 2012;25(7): 746–55. doi:10.1038/ajh.2012.42</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sopić M, Joksić J, Spasojević-Kalimanovska V, Kalimanovska-Oštrić D, Anđelković K, Jelić-Ivanović Z. Are decreased AdipoR1 mRNA levels associated with adiponectin resistance in coronary artery disease patients? Clin Exp Pharmacol Physiol. 2015;42(4):331–6. doi:10.1111/1440-1681.12361.</mixed-citation><mixed-citation xml:lang="en">Sopić M, Joksić J, Spasojević-Kalimanovska V, Kalimanovska-Oštrić D, Anđelković K, Jelić-Ivanović Z. Are decreased AdipoR1 mRNA levels associated with adiponectin resistance in coronary artery disease patients? Clin Exp Pharmacol Physiol. 2015;42(4):331–6. doi:10.1111/1440-1681.12361.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика и лечение артериальной гипертонии. Клинические рекомендации. Кардиологический вестник. 2015;1:5– 30. URL: http://cardioweb.ru/files/Cardiovest/Kardiovest_1_2015. pdf [Diagnosis and treatment of hypertension. Clinical guidelines. Kardiologicheskii Vestnik=Cardiologic Bulletin. 2015;1:5–30. URL: http://cardioweb.ru/files/Cardiovest/Kardiovest_1_2015. pdf. In Russian].</mixed-citation><mixed-citation xml:lang="en">Диагностика и лечение артериальной гипертонии. Клинические рекомендации. Кардиологический вестник. 2015;1:5– 30. URL: http://cardioweb.ru/files/Cardiovest/Kardiovest_1_2015. pdf [Diagnosis and treatment of hypertension. Clinical guidelines. Kardiologicheskii Vestnik = Cardiologic Bulletin. 2015;1:5–30. URL: http://cardioweb.ru/files/Cardiovest/Kardiovest_1_2015. pdf. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. The 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013 Jul;34(28):2159–219. doi:10.1093/eurheartj/eht151</mixed-citation><mixed-citation xml:lang="en">Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. The 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013 Jul;34(28):2159–219. doi:10.1093/eurheartj/eht151</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liu XH, Yang YW, Dai HT, Cai SW, Chen RH, Ye ZQ. Protective role of adiponectin in a rat model of intestinal ischemia reperfusion injury. World J Gastroenterol. 2015;21(47):13250–8. doi:10.3748/wjg.v21.i47.13250</mixed-citation><mixed-citation xml:lang="en">Liu XH, Yang YW, Dai HT, Cai SW, Chen RH, Ye ZQ. Protective role of adiponectin in a rat model of intestinal ischemia reperfusion injury. World J Gastroenterol. 2015;21(47):13250–8. doi:10.3748/wjg.v21.i47.13250</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yu L, Tu Q, Han Q, Zhang L, Sui L, Zheng L et al. Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes. Stem Cells. 2015;33(1):240–52. doi:10.1002/stem.1844</mixed-citation><mixed-citation xml:lang="en">Yu L, Tu Q, Han Q, Zhang L, Sui L, Zheng L et al. Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetes. Stem Cells. 2015;33(1):240–52. doi:10.1002/stem.1844</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli MF, Hoes AW, Agewall S, Albus Ch, Brotons C, Alberico L et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:org/10.1093/eurheartj/ehw106</mixed-citation><mixed-citation xml:lang="en">Piepoli MF, Hoes AW, Agewall S, Albus Ch, Brotons C, Alberico L et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi:org/10.1093/eurheartj/ehw106</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nosalski R, Guzik, TJ. Perivascular adipose tissue inflammation invascular disease. Br J Pharmacol. 2017;174(20):3496–3513. doi:10.1111/bph.13705</mixed-citation><mixed-citation xml:lang="en">Nosalski R, Guzik, TJ. Perivascular adipose tissue inflammation invascular disease. Br J Pharmacol. 2017;174(20):3496–3513. doi:10.1111/bph.13705</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Цветков Д., Сийарто И.А., Ванг Н., Тано Й.И., Голлах М. Сосудистая дисфункция и периадвентициальная жировая ткань. Тихоокеанский медицинский журнал. 2016;2:31–33. doi:10.17238/1609-1175.2016.2.31 [Tsvetkov D, SzijártóIA, Wang N, Tano JY, Gollasch M. Vascular dysfunction and periadventitial adipose tissue. Pacific Medical Journal. 2016;2:31–33. doi:10.17238/1609-1175.2016.2.31 In Russian].</mixed-citation><mixed-citation xml:lang="en">Цветков Д., Сийарто И.А., Ванг Н., Тано Й.И., Голлах М. Сосудистая дисфункция и периадвентициальная жировая ткань. Тихоокеанский медицинский журнал. 2016;2:31–33. doi:10.17238/1609-1175.2016.2.31 [Tsvetkov D, SzijártóIA, Wang N, Tano JY, Gollasch M. Vascular dysfunction and periadventitial adipose tissue. Pacific Medical Journal. 2016;2:31–33. doi:10.17238/ 1609-1175.2016.2.31 In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Haque Z, Lakho GR, Nafees M, Shahid KU, MazahirI. Serum leptin levels correlation with high blood pressure in adult females. Journal of the College of Physicians and Surgeons Pakistan. 2006;16 (7):450–4. doi:7.2006/JCPSP.450454</mixed-citation><mixed-citation xml:lang="en">Haque Z, Lakho GR, Nafees M, Shahid KU, MazahirI. Serum leptin levels correlation with high blood pressure in adult females. Journal of the College of Physicians and Surgeons Pakistan. 2006;16 (7):450–4. doi:7.2006/JCPSP.450454</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor PD, Samuelsson AM, Poston L. Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta physiologica (Oxf). 2014;210(3):508–23. doi:10.1111/apha.12223</mixed-citation><mixed-citation xml:lang="en">Taylor PD, Samuelsson AM, Poston L. Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta physiologica (Oxf). 2014;210(3):508–23. doi:10.1111/ apha.12223</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ouchi N, Kihara S, Arita Y, Matsuyama A, Okamoto Y, Ishigami M et al. Adipocyte-derived plasma protein adiponectin, suppress lipid accumulation and class A scavenger receptor expression in human monocyte— derived macrophages. Circulation 2001;103(8):1057–1063. doi:10.1161/01.CIR.103.8.1057</mixed-citation><mixed-citation xml:lang="en">Ouchi N, Kihara S, Arita Y, Matsuyama A, Okamoto Y, Ishigami M et al. Adipocyte-derived plasma protein adiponectin, suppress lipid accumulation and class A scavenger receptor expression in human monocyte— derived macrophages. Circulation 2001;103(8):1057–1063. doi:10.1161/01.CIR.103.8.1057</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nishizawa H, ShimomuraI, Kishida K, Maeda N, Kuriyama H, Nagaretani H et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51 (9):2734–41. https://doi.org/10.2337/diabetes.51.9.2734</mixed-citation><mixed-citation xml:lang="en">Nishizawa H, ShimomuraI, Kishida K, Maeda N, Kuriyama H, Nagaretani H et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51 (9):2734–41. https://doi.org/10.2337/diabetes.51.9.2734</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Selthofer-Relatić K, Radić R, Vcev A, Steiner R, Vizjak V, Sram M et al. Low adiponectin serum level reduced protective effect on the left ventricular wall thickness. Collegium Antropologicum. 2011;35(3):787–91.</mixed-citation><mixed-citation xml:lang="en">Selthofer-Relatić K, Radić R, Vcev A, Steiner R, Vizjak V, Sram M et al. Low adiponectin serum level reduced protective effect on the left ventricular wall thickness. Collegium Antropologicum. 2011;35(3):787–91.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab. 2009;296(1): E22 E36. doi:10.1152/ajpendo.90731.2008</mixed-citation><mixed-citation xml:lang="en">Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab. 2009;296(1): E22 E36. doi:10.1152/ajpendo.90731.2008</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51. doi:10.1210/er.2005- 0005</mixed-citation><mixed-citation xml:lang="en">Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51. doi:10.1210/er.2005- 0005</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M et al. An adipocyte-derived plasma protein adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32(2):47– 50. doi:10.1055/s2007-978586</mixed-citation><mixed-citation xml:lang="en">Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M et al. An adipocyte-derived plasma protein adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32(2):47– 50. doi:10.1055/s 2007-978586</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z, Wang F, Wang BJ, Chu G, Cao Q, Sun BG et al. Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin. J Mol Endocrinol. 2014;53(2):145–54. doi:10.1530/JME14-0027</mixed-citation><mixed-citation xml:lang="en">Zhang Z, Wang F, Wang BJ, Chu G, Cao Q, Sun BG et al. Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin. J Mol Endocrinol. 2014;53(2):145–54. doi:10.1530/JME 14-0027</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Schinzari F, Tesauro M, Cardillo C. Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease. Acta Physiologica (Oxf). 2017;219(1):124–137. doi:10.1111/apha.12630</mixed-citation><mixed-citation xml:lang="en">Schinzari F, Tesauro M, Cardillo C. Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease. Acta Physiologica (Oxf). 2017;219(1):124–137. doi:10. 1111/apha.12630</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Du Y, Li R, Lau WB, Zhao J, Lopez B, Christopher TA et al. Adiponectin at physiologically relevant concentrations enhances the vasorelaxative effect of acetylcholine via Cav 1/adipor 1 signaling. PLoS One. 2016;11(3): e0152247. doi:10.1371/journal.pone.0152247</mixed-citation><mixed-citation xml:lang="en">Du Y, Li R, Lau WB, Zhao J, Lopez B, Christopher TA et al. Adiponectin at physiologically relevant concentrations enhances the vasorelaxative effect of acetylcholine via Cav 1/adipor 1 signaling. PLoS One. 2016;11(3): e0152247. doi:10.1371/journal. pone.0152247</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Luo N, Chung BH, WangX, Klein RL, Tang CK, Garvey WT et al. Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 2013;228(1):124–35. doi:10.1016/j.atherosclerosis.2013.02.026</mixed-citation><mixed-citation xml:lang="en">Luo N, Chung BH, WangX, Klein RL, Tang CK, Garvey WT et al. Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 2013;228(1):124–35. doi:10.1016/j.atherosclerosis.2013.02.026</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Koentges C, König A, Pfeil K, Hölscher ME, Schnick T, Wende AR et al. Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1. Bas Res Cardiol. 2015;110(4):37. doi:10.1007/s00395-015-0495-4</mixed-citation><mixed-citation xml:lang="en">Koentges C, König A, Pfeil K, Hölscher ME, Schnick T, Wende AR et al. Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1. Bas Res Cardiol. 2015;110(4):37. doi:10.1007/s00395-015-0495-4</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Luo N, Chung BH, WangX, Klein RL, Tang CK, Garvey WT et al. Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 2013;228(1):124–35. doi:10.1016/j.atherosclerosis.2013.02.026</mixed-citation><mixed-citation xml:lang="en">Luo N, Chung BH, WangX, Klein RL, Tang CK, Garvey WT et al. Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis. 2013;228(1):124–35. doi:10.1016/j.atherosclerosis.2013.02.026</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Rodríguez A, Catalán V, Becerril S, Gil MJ, Mugueta C, Gómez-Ambrosi J et al. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Science. 2008;83(15–16):540–9. doi:10.1016/j.lfs.2008.07.022</mixed-citation><mixed-citation xml:lang="en">Rodríguez A, Catalán V, Becerril S, Gil MJ, Mugueta C, Gómez-Ambrosi J et al. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Science. 2008;83(15–16):540–9. doi:10.1016/j.lfs.2008.07.022</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Gackowska L, Litwin M, Trojanek J, Eljaszewicz A, Kubiszewska I, Niemirska A et al. Expression of adiponectin receptors on peripheral blood leukocytes of hypertensive children is associated with the severity of hypertension. BioMed Res Intern. 2015;2015:742646. doi:10.1155/2015/742646</mixed-citation><mixed-citation xml:lang="en">Gackowska L, Litwin M, Trojanek J, Eljaszewicz A, Kubiszewska I, Niemirska A et al. Expression of adiponectin receptors on peripheral blood leukocytes of hypertensive children is associated with the severity of hypertension. BioMed Res Intern. 2015;2015:742646. doi:10.1155/2015/742646</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
